Can Huang

The company’s technology development is currently led by Dr. Can Huang. He is the Chief Operation Officer of HelioWave Technologies, LLC., where he exploits his expertise in microfluidic system development and microfabrication technologies to develop novel instruments for the biopharmaceutical industry. Previously, he was a postdoctoral researcher in the NanoBio Systems Lab (Advisor: Prof. Arum Han) at Texas A&M University. He holds degrees from Tsinghua University (B.S., Electrical Engineering), Rice University (M.S., Electrical Engineering), and Texas A&M University (Ph.D., Electrical Engineering). His research focuses on developing microfluidic lab-on-a-chip systems for microorganisms, point-of-care diagnosis applications, as well as novel microsystems for biomedical applications. He has participated and is currently serving as a core researcher member in projects supported by the Bill & Melinda Gates Foundation, NIH, NSF, DARPA, and ARL. He is also leading a DARPA-funded SBIR Phase II project to develop HelioSAFE sterility detection system. These experiences have provided him with valuable multidisciplinary research experience and skill sets. He has also participated in the NSF-iCORP program in 2019 and received training and mentorship through interactions with the Texas A&M McFerrin Center for Entrepreneurship.